Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nelfinavir with Chemoradiation for Locally Advanced Cervical Cancer
NCT02363829Phase 1Completed
- Sponsor
- Abramson Cancer Center
- Start
- Feb 2015
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of nelfinavir in Cervical Cancer (CC), sponsored by Abramson Cancer Center. Primary endpoint: Number of Adverse Events at 2 years. Started Feb 2015; status: completed.
02
Drugs
nelfinavir
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT02363829.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02363829.